Table 5.
Therapies utilized until the time of enrollment in men and women with chronic pancreatitis enrolled in the NAPS2-CV study
| N (%) | All (N=521) | Alcohol (N=238) | Idiopathic (N=126) | Obstructive (N=36) | ||||
|---|---|---|---|---|---|---|---|---|
| Men (N=287) |
Women (N=234) |
Men (N=167) |
Women (N=71) |
Men (N=52) |
Women (N=74) |
Men (N=7) | Women (N=29) |
|
| Medical Therapies | ||||||||
| Oral PERT | 192 (67) | 165 (70) | 110 (66) | 53 (75) | 37 (71) | 48 (65) | 4 (57) | 25 (86) |
| Vitamins/Antioxidants | 76 (27) | 69 (29) | 49 (29) | 20 (28) | 12 (23) | 19 (26) | 2 (29) | 11 (38) |
| Celiac nerve block | 16 (6) | 9 (4) | 8 (5) | 2 (3) | 1 (2) | 5 (7) | 1 (14) | 0 (0) |
| Endoscopic Therapies | ||||||||
| Biliary Sphincterotomy | 69 (24) | 78 (33)* | 33 (20) | 18 (25) | 13 (25) | 33 (45)* | 1 (14) | 11 (38) |
| Pancreatic Sphincterotomy | 79 (28) | 89 (38)* | 40 (24) | 20 (28) | 14 (27) | 36 (49)* | 4 (57) | 17 (59) |
| Bile Duct Stenting | 37 (13) | 23 (10) | 20 (12) | 8 (11) | 7 (14) | 7 (10) | 0 (0) | 4 (14) |
| Pancreatic Duct Stenting | 74 (26) | 78 (33) | 37 (22) | 26 (37)* | 17 (33) | 27 (37) | 1 (14) | 13 (45) |
| Pancreatic duct Stone removal | 40 (14) | 39 (17) | 21 (13) | 14 (20) | 5 (10) | 15 (20) | 1 (14) | 5 (17) |
| Surgical Therapies | ||||||||
| Cholecystectomy | 67 (23) | 89 (38)* | 28 (17) | 22 (31)* | 14 (27) | 32 (43) | 3 (43) | 11 (38) |
| Partial/Complete Pancreatectomy | 32 (11) | 27 (12) | 20 (12) | 5 (7) | 3 (6) | 7 (10) | 0 (0) | 6 (21) |
| Drainage surgery | 19 (7) | 14 (6) | 16 (10) | 3 (4) | 0 (0) | 4 (5) | 0 (0) | 3 (10) |
| Cyst/Pseudocyst Operation | 19 (7)* | 6 (3) | 14 (8)* | 1 (1) | 3 (6) | 2 (3) | 0 (0) | 0 (0) |
PERT: pancreatic enzyme replacement therapy
*
P-value ≤ 0.05 for differences in utilization of therapy